Salomon Azoulay
Net worth: 815 249 $ as of 2026-06-29
Net worth: 815 249 $ as of 2026-06-29
Salomon Azoulay currently works at MBX Biosciences, Inc., as Chief Medical Officer from 2024.
Dr. Azoulay also formerly worked at Pfizer Essential Health, as Chief Medical Officer from 2013 to 2018, Sumitomo Pharma UK Holdings Ltd., as Chief Medical Officer from 2021 to 2023, and Roivant Sciences, Inc., as Chief Medical Officer from 2018 to 2020.
Dr. Azoulay received his undergraduate degree and doctorate degree from Sorbonne Université.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-07 | 14,769 ( 0.03% ) | 815 249 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| MBX BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2024-05-31 |
| Companies | Position | End |
|---|---|---|
Sumitomo Pharma UK Holdings Ltd.
Sumitomo Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in provides biopharmaceutical services | Chief Tech/Sci/R&D Officer | 2023-06-30 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Chief Tech/Sci/R&D Officer | 2020-11-30 |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | 2018-04-30 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Sorbonne Université
Sorbonne Université Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
MBX Biosciences, Inc.
MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Sumitomo Pharma UK Holdings Ltd.
Sumitomo Pharma UK Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interests in provides biopharmaceutical services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions